# TB-500

TB-500 has 1 registered human trial. It is marketed for 3 different uses.

**In short**

- 1 registered human trial exists for TB-500.
- TB-500 is not FDA-approved for any use.
- What has actually been studied: atherosclerotic cardiovascular diseases, endothelial dysfunction.
- Last checked against ClinicalTrials.gov on 2026-07-27.

## What it is sold for

- Soft-tissue & tendon recovery
- Injury healing
- Hair growth

## What has actually been tested

- Atherosclerotic Cardiovascular Diseases
- Endothelial Dysfunction

## Every trial on record

| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| [NCT07487363](https://clinicaltrials.gov/study/NCT07487363) | TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD | Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction | Phase 2 | RECRUITING | 80 |

## Common questions

**How many human trials does TB-500 have?**
1, each listed above with a link to its original record.

**Is TB-500 FDA approved?**
No. It is not approved by the FDA for any indication.

**Where does this data come from?**
ClinicalTrials.gov. We count interventional human studies only. Every trial
links to its original record.

---

*Automated aggregation from public registries. Not medical advice. No physician
has reviewed this page. Source: https://www.whatsactuallyknown.com/compounds/tb-500*